GlassScriptPhysician profile
Jordan Gulley
NPI 1609400183
$7,930.27
in general payments reported to CMS, 2019-2025
73 companies · $3,108 in 2025
The $3,108 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,154 · 2022: $1,492 · 2023: $666 · 2024: $1,510 · 2025: $3,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,068 · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,068.05 |
| Education | $215.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $553.21 | 2021-2025 | Padcev, Xospata, Vyloy |
| Myovant Sciences INC. | $416.94 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $403.59 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $391.85 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $347.21 | 2021-2025 | Tagrisso, Imfinzi, Lynparza |
| Daiichi Sankyo INC. | $313.78 | 2024-2025 | Enhertu, Datroway, Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $255.15 | 2024-2025 | Iclusig, Alunbrig, Ninlaro |
| Urovant Sciences INC | $241.86 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $221.40 | 2023-2025 | Fotivda |
| Regeneron Healthcare Solutions, INC. | $220.58 | 2023-2025 | Libtayo |
| Janssen Biotech, INC. | $211.17 | 2022-2025 | Talvey, Darzalex, Rybrevant |
| Pfizer INC. | $209.17 | 2021-2025 | |
| Exelixis INC. | $202.47 | 2023-2025 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $200.29 | 2021-2025 | |
| Glaxosmithkline, LLC. | $179.17 | 2024-2025 | Ojjaara, Zejula, Jemperli |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beigene USA, INC. | $173.29 | 2024 | Brukinsa, Tevimbra |
| Seagen INC. | $168.46 | 2023 | Padcev, Tukysa |
| Merck Sharp & Dohme LLC | $161.01 | 2022-2025 | Keytruda, Lynparza |
| Abbvie INC. | $144.16 | 2021-2025 | |
| Deciphera Pharmaceuticals INC. | $141.21 | 2025 | Qinlock, Romvimza |
| Novocure INC. | $141.04 | 2025 | Optune Lua (Novottf-200t) |
| Genentech USA, INC. | $134.70 | 2024-2025 | Itovebi, Venclexta, Tecentriq |
| Incyte Corporation | $128.38 | 2024-2025 | Monjuvi, Zynyz, Jakafi |
| Tolmar Pharmaceuticals, INC. | $124.85 | 2021-2022 | |
| Kite Pharma, INC. | $107.15 | 2023 | |
| Axonics, INC. | $106.41 | 2022-2023 | Bulkamid |
| Eisai INC. | $95.94 | 2024-2025 | |
| Beone Medicines USA, INC. | $94.96 | 2025 | Tevimbra, Brukinsa |
| Rochester Medical Corporation | $81.60 | 2021 | |
| Genzyme Corporation | $79.34 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.05 | 2024-2025 | Gilotrif |
| Rigel Pharmaceuticals, INC. | $75.21 | 2025 | Gavreto, Rezlidhia, Tavalisse |
| Alexion Pharmaceuticals, INC. | $75.13 | 2024-2025 | Ultomiris |
| Antares Pharma, INC. | $75.05 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $73.34 | 2023-2025 | Yonsa, Odomzo |
| Angiodynamics, INC. | $69.65 | 2022 | |
| Innovation Technologies INC | $65.00 | 2022 | |
| Legend Biotech USA INC. | $64.52 | 2025 | Carvykti |
| Endo Pharmaceuticals INC. | $63.46 | 2021-2022 | |
| Geron Corporation | $63.04 | 2025 | Rytelo |
| Blue Earth Diagnostics | $59.30 | 2021 | |
| Genmab U.S., INC. | $52.57 | 2024-2025 | Epkinly |
| Gilead Sciences, INC. | $51.80 | 2025 | Trodelvy |
| Tersera Therapeutics LLC | $51.51 | 2024 | Xermelo, Zoladex |
| Pharmaessentia USA Corporation | $50.72 | 2024-2025 | Besremi |
| Emd Serono, INC. | $50.33 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $49.50 | 2025 | Onivyde |
| Taiho Oncology, INC. | $49.30 | 2024 | |
| Pharmacosmos Therapeutics INC. | $46.28 | 2024-2025 | Cosela, Monoferric |
| Fennec Pharmaceuticals, INC. | $42.53 | 2025 | Fyarro |
| Boston Scientific Corporation | $33.18 | 2021 | |
| Progenics Pharmaceuticals, INC. | $28.33 | 2022 | |
| Avyxa Pharma, LLC | $28.01 | 2025 | |
| Teleflex LLC | $27.19 | 2022 | |
| Mirati Therapeutics, INC. | $24.53 | 2024 | Krazati |
| Iovance Biotherapeutics, INC. | $24.40 | 2025 | Amtagvi |
| Convatec INC. | $24.21 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.53 | 2021 | |
| Celgene Corporation | $22.67 | 2024 | Pomalyst |
| Urogen Pharma, INC. | $22.66 | 2022 | |
| Stemline Therapeutics INC. | $22.30 | 2025 | Orserdu |
| Palette Life Sciences, INC. | $21.82 | 2022 | |
| Agios Pharmaceuticals, INC. | $20.09 | 2025 | Pyrukynd |
| Cycle Pharmaceuticals INC | $19.25 | 2025 | Phyrago |
| Clovis Oncology, INC. | $18.95 | 2022 | |
| Medtronic, INC. | $17.97 | 2022 | |
| Sumitomo Pharma America, INC. | $17.17 | 2025 | Orgovyx |
| Caris Mpi, INC. | $16.70 | 2025 | Mi Cancer Seek |
| Adc Therapeutics America, INC. | $16.27 | 2025 | |
| Lilly USA, LLC | $15.59 | 2025 | Verzenio, Retevmo, Jaypirca |
| Coloplast Corp | $14.40 | 2023 | Speedicath |
| Acerus Pharmaceuticals Corporation | $11.93 | 2021 | |
| Travere Therapeutics, INC. | $2.49 | 2022 |
Drugs and devices associated with these payments
Fotivda $221Libtayo $221Cabometyx $202Enhertu $196Iclusig $187Brukinsa $185Padcev $169Tagrisso $142Qinlock $141Optune Lua (Novottf-200t) $141Kisqali $134Scemblix $122Talvey $110Epkinly $98.67Lenvima $95.94Nubeqa $94.31Ojjaara $94.09Venclexta $93.76Romvimza $87.55Tevimbra $83.59Keytruda $80.44Darzalex $79.43Rybrevant $78.40Gilotrif $78.05Imbruvica $77.93Gavreto $75.21Tavalisse $75.21Rezlidhia $75.21Ultomiris $75.13Odomzo $73.34Imfinzi $71.98Xofigo $71.08Tukysa $68.74Pluvicto $67.08Monjuvi $66.58Zynyz $66.58Carvykti $64.52Rytelo $63.04Itovebi $62.47Jakafi $61.80Elrexfio $60.51Adcetris $60.51Lynparza $51.84Trodelvy $51.80Besremi $50.72Onivyde $49.50Inqovi $49.30Lonsurf $49.30Sarclisa $49.22Fabhalta $48.17Yonsa $45.82Zejula $45.01Jemperli $45.01Tecvayli $43.43Fyarro $42.53Orgovyx $41.05Blenrep $40.07Alunbrig $34.22Ninlaro $33.78Jevtana $30.12Tecentriq $30.10Datroway $29.97Xermelo $29.42Docivyx $28.01Axtle $28.01Frindovyx $28.01Bulkamid $25.46Krazati $24.53Injectafer $24.46Amtagvi $24.40Cosela $24.24Talzenna $23.88Xtandi $23.88Xospata $23.85Vitrakvi $23.23Stivarga $23.23Pomalyst $22.67Orserdu $22.30Ibrance $22.13Zoladex $22.09Monoferric $22.04Bosulif $22.01Lutathera $20.70Pyrukynd $20.09Phyrago $19.25Vyloy $18.83Mi Cancer Seek $16.70Zynlonta $16.27Jaypirca $15.59Verzenio $15.59Retevmo $15.59Phesgo $15.20Erleada $14.86Speedicath $14.40
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Gulley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.